Dirk Schrader

CEO and Co-Founder at Goodly Innovations GmbH

Dirk Schrader has a significant work experience spanning multiple companies and roles. Dirk is currently the CEO and Co-Founder of Goodly Innovations GmbH, a position they have held since December 2016. Dirk is also an Advisory Board Member and Non-Executive Director at AMW GmbH, a rapidly expanding pharmaceuticals company.

Previously, Dirk served as the Global Head of Contract Manufacturing Business at Insud Pharma from April 2020 to August 2022. Dirk was responsible for leading the Tech Ops of Chemo and Exeltis, Global Supply Chain, and Procurement. Dirk was also a member of the Executive Committee.

Prior to that, they worked at Vifor Pharma from March 2012 to April 2020, where they held the position of Executive Vice President and Head of Global Technical Operations. In this role, they oversaw various functions such as Integrated Industrial Operations, Supply Chain, Technical Project Management, Pharmaceutical Development, Group Procurement, and Global Quality Management.

Dirk's career includes stints at AstraZeneca, where they served as VP Lean, Global Operations, and VP Supply Asia Pacific & Japan, Global Operations. Dirk also held the position of VP Tech Ops Asia Pacific/Japan at Bristol-Myers Squibb.

Before joining AstraZeneca and Bristol-Myers Squibb, Dirk worked at Bayer HealthCare for a significant period. Dirk held various roles, including Head of Commercial Operations, General Manager Taiwan, and SVP Tech Ops International. Dirk was accountable for Bayer Pharma Technical Operations across different regions and has also established and led the first Bayer Pharma site in Beijing.

Dirk Schrader's education history includes attending the University of Münster and Freie Universität Berlin, although the specific degrees or fields of study are not provided. Dirk also attended Ratsgymnasium Peine and Technische Universität Braunschweig, but again, the details of their degree or field of study are not mentioned. In addition to their formal education, Dirk Schrader obtained the FT Non-Executive Director Diploma from the Pearson SRF BTEC Level 7 Advanced Professional Diploma program offered by FT Board Director Programme in March 2022.

Links

Previous companies

AstraZeneca logo
Bayer logo
Bristol-Myers Squibb logo

Org chart

Sign up to view 4 direct reports

Get started